GE and InDevR Scientists Developing Breakthrough Device to Improve Diagnosis ...
Central technology development
arm, have been awarded a program through the Defense Advanced Research
Projects Agency (DARPA) to develop a breakthrough medical device that
can diagnose the flu and other infectious diseases such as malaria, E.
coli and salmonella at the point-of-care. In addition to making an
accurate diagnosis, another key goal of the device is to be readily
adapted for new strains of diseases so that new diagnostic tests can be
GE And InDevR Scientists Developing Breakthrough Device To
GE scientists will be partnering with InDevR, a rapidly growing
biotechnology company in Boulder, Colorado that develops new tools to
assist in disease diagnosis such as the flu and vaccine development as
well. GE, with deep research experience in chemistry and world-class
experts in DNA and RNA analysis, will be incorporating new materials and
molecular biology methods into a device being developed by InDevR. The
nearly $5.8 million in funding from DARPA for the project will result in
the creation of at least 7 new jobs at InDevR.